Your browser doesn't support javascript.
loading
Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study.
Yasui-Furukori, Norio; Muraoka, Hiroyuki; Hasegawa, Naomi; Ochi, Shinichiro; Numata, Shusuke; Hori, Hikaru; Hishimoto, Akitoyo; Onitsuka, Toshiaki; Ohi, Kazutaka; Hashimoto, Naoki; Nagasawa, Tatsuya; Takaesu, Yoshikazu; Inagaki, Takahiko; Tagata, Hiromi; Tsuboi, Takashi; Kubota, Chika; Furihata, Ryuji; Iga, Jun-Ichi; Iida, Hitoshi; Miura, Kenichiro; Matsumoto, Junya; Yamada, Hisashi; Watanabe, Koichiro; Inada, Ken; Shimoda, Kazutaka; Hashimoto, Ryota.
Afiliação
  • Yasui-Furukori N; Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan.
  • Muraoka H; Department of Psychiatry, Tokyo Women's Medical University, Tokyo, Japan.
  • Hasegawa N; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Ochi S; Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Numata S; Department of Psychiatry, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan.
  • Hori H; Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
  • Hishimoto A; Department of Psychiatry, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
  • Onitsuka T; Department of Neuroimaging Psychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Ohi K; Department of Psychiatry, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Hashimoto N; Department of Psychiatry, Hokkaido University Graduate School of Medicine, Hokkaido, Japan.
  • Nagasawa T; Department of Neuro-Psychiatry, Kanazawa Medical University, Kanazawa, Japan.
  • Takaesu Y; Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Inagaki T; Adolescent Mental Health Service, Biwako Hospital, Shiga, Japan.
  • Tagata H; Department of Neuropsychiatry, Toho University Graduate School of Medicine, Tokyo, Japan.
  • Tsuboi T; Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.
  • Kubota C; National Center of Neurology and Psychiatry Hospital, Tokyo, Japan.
  • Furihata R; Kyoto University Health Services, Kyoto, Japan.
  • Iga JI; Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Iida H; Department of Psychiatry, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan.
  • Miura K; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Matsumoto J; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Yamada H; Department of Neuropsychiatry, Hyogo College of Medicine, Hyogo, Japan.
  • Watanabe K; Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.
  • Inada K; Department of Psychiatry, Tokyo Women's Medical University, Tokyo, Japan.
  • Shimoda K; Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan.
  • Hashimoto R; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Neuropsychopharmacol Rep ; 42(1): 3-9, 2022 03.
Article em En | MEDLINE | ID: mdl-34854260
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Clozapina Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: Neuropsychopharmacol Rep Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Clozapina Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: Neuropsychopharmacol Rep Ano de publicação: 2022 Tipo de documento: Article